Bicalutamide Therapy in Young Women With NAFLD and PCOS

Recruiting

Phase 1

Bicalutamide Therapy in Young Women With NAFLD and PCOSBicalutamide Therapy in Young Women With NAFLD and PCOS

Sponsor:

UCLA

Code:

NCT05979389

Conditions

NAFLD

PCOS

Eligibility Criteria

Sex: Female

Age: 18 - 40

Healthy Volunteers: Not accepted

Interventions

Bicalutamide 50 mg

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-30. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2024-05-02.